Drug
Ceftobiprole medocaril clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 8
- first study started
- 2004
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 1
Basilea Pharmaceutica (10) · Centre Hospitalier Universitaire Dijon (1)
Studies
Open first, then newest update. How each study uses ceftobiprole medocaril is read from its arms, and is right about nine times in ten.
Testing it · 11
- Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus BacteremiaCompletedPhase 3Basilea PharmaceuticaNCT03138733Written as Ceftobiprole medocaril
- Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure InfectionsCompletedPhase 3Basilea PharmaceuticaNCT03137173Written as ceftobiprole medocaril
- Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of AgeCompletedPhase 3Basilea PharmaceuticaNCT05856227Written as Ceftobiprole medocaril
- Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic AntibioticsTerminatedPhase 1Basilea PharmaceuticaNCT02527681Written as Ceftobiprole medocaril
- Ceftobiprole in the Treatment of Pediatric Patients With PneumoniaCompletedPhase 3Basilea PharmaceuticaNCT03439124Written as ceftobiprole medocaril
- Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF DeviceCompletedPhase 2Centre Hospitalier Universitaire DijonNCT03317093Written as Ceftobiprole Medocaril
- Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus BacteremiaWithdrawnPhase 2Basilea PharmaceuticaNCT00505258Written as ceftobiprole medocaril
- Ceftobiprole in the Treatment of Patients With Community-Acquired PneumoniaCompletedPhase 3Basilea PharmaceuticaNCT00326287Written as Ceftobiprole medocaril
- A Study of Ceftobiprole in Patients With Fever and Neutropenia.TerminatedPhase 3Basilea PharmaceuticaNCT00529282Written as Ceftobiprole Medocaril
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsCompletedPhase 3Basilea PharmaceuticaNCT00228982Written as Ceftobiprole medocaril
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsCompletedPhase 3Basilea PharmaceuticaNCT00210899Written as ceftobiprole medocaril
Codes
What other systems call ceftobiprole medocaril · ClinicalTrials.gg INT004834
- MeSH (NLM) C505439ceftobiprole medocarilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) N99027V28JCEFTOBIPROLE MEDOCARIL SODIUMConfirmed FDA, NLM, Wikidata
- Wikidata Q27284724ceftobiprole medocaril sodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C70597Ceftobiprole Medocaril SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C505439 | ceftobiprole medocaril | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | N99027V28J | CEFTOBIPROLE MEDOCARIL SODIUM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27284724 | ceftobiprole medocaril sodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C70597 | Ceftobiprole Medocaril Sodium | One source FDA |
Also registered as ceftobiprole medocaril free acid (UNII YXV28V1B07).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.